Reports for BUPRENORPHINE
Ingredient
BUPRENORPHINE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167203 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Actual shortage | 2024-03-07 | 2024-03-28 | 221534 |
| MYLAN-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-22 | 2017-04-12 | 3922 |
| MYLAN-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-04-20 | 2019-09-18 | 7392 |
| SUBOXONE | 2MG 8MG | FILM, SOLUBLE | Resolved | 2023-04-13 | 2023-05-19 | 189554 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Actual shortage | 2024-03-07 | 2024-03-28 | 221537 |
| SUBLOCADE | 300MG | SOLUTION (EXTENDED RELEASE) | Resolved | 2020-09-01 | 2021-01-27 | 123466 |
| SUBLOCADE | 300MG | SOLUTION (EXTENDED RELEASE) | Resolved | 2022-02-24 | 2022-03-03 | 155534 |
| BUTRANS 5 | 5MCG | PATCH | Resolved | 2021-05-13 | 2021-05-27 | 139259 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-BUPRENORPHINE/NALOXONE | Discontinued | 2019-09-17 | 2019-09-18 | 94044 | ||
| BELBUCA | 150MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80230 |
| BELBUCA | 300MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80233 |
| BELBUCA | 450MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80236 |
| BELBUCA | 75MCG | FILM, SOLUBLE | Discontinued | 2019-03-28 | 2019-04-02 | 79766 |
| MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94048 |
Showing 1 to 6 of 6